Clinical Trial Update: Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients [Phase 4]

View source ↗

Summary

A Phase 4 safety study evaluating the combination of lopinavir/ritonavir with raltegravir in HIV-infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)
• Kaletra (lopinavir)

Snippet

Sponsor: Saint Michael's Medical Center | Conditions: HIV Infections | Phase 4 | Status: COMPLETED